[1]
M. Veltkamp, M. Drent, and R. P. Baughman, “Infliximab or biosimilars in sarcoidosis; to switch or not to switch?”,
Sarcoidosis Vasc Diffuse Lung Dis, vol. 32, no. 4, pp. 280–283, Jan. 2016, Accessed: Jul. 13, 2025. [Online]. Available:
https://mattioli1885journals.com/index.php/sarcoidosis/article/view/5001